Back
Lamar Advertising Vs. Aligos Therapeutics Industry Stock Comparison
Buy
52
LAMR
Lamar Advertising
Last Price:
$123.04
Seasonality Move:
1.57%
Buy
65
ALGS
Aligos Therapeutics
Last Price:
$39.78
Seasonality Move:
7.18%
Buy
52
Lamar Advertising (LAMR)
is a Buy
Is Lamar Advertising a Buy, Sell or Hold?
-
The current Lamar Advertising [LAMR] share price is $122.99. The Score for LAMR is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
LAMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $39.78. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LAMR Stock Price Chart
What is Lamar Advertising's stock price today?
-
The Lamar Advertising share price today is $122.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LAMR is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $39.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight buying pressure.
LAMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.87 | Sell |
Relative Strength Index (14 RSI): | 30.65 | Sell |
Chaikin Money Flow: | -339732 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (126.16 - 132.9) | Sell |
Bollinger Bands (100): | (121.76 - 134.44) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.35 | Buy |
Relative Strength Index (14 RSI): | 80.7 | Buy |
Chaikin Money Flow: | 139105 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.75 - 33.69) | Buy |
Bollinger Bands (100): | (7.04 - 23.32) | Buy |
LAMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 126.66 | Sell |
20-day SMA: | 129.99 | Sell |
50-day SMA: | 131.39 | Sell |
200-day SMA: | 122.59 | Buy |
8-day EMA: | 125.92 | Sell |
20-day EMA: | 128.41 | Sell |
50-day EMA: | 129.58 | Sell |
200-day EMA: | 122.33 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.12 | Buy |
20-day SMA: | 29.23 | Buy |
50-day SMA: | 18.61 | Buy |
200-day SMA: | 16.23 | Buy |
8-day EMA: | 34.99 | Buy |
20-day EMA: | 29.85 | Buy |
50-day EMA: | 22.37 | Buy |
200-day EMA: | 17.42 | Buy |
Lamar Advertising Earnings Growth & LAMR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.94 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Lamar Advertising Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |